Atropine 0.05% has double the efficacy of 0.01% eye drops over 2 years, and the former remains the optimal concentration among atropine concentrations in slowing the progression of myopia, a recent study has shown.
Gravitational displacement of submacular haemorrhage (SMH) after pars planar vitrectomy appears to be an effective intervention, particularly in combination with subretinal tissue plasminogen activator and intravitreal anti-vascular endothelial growth factor, a recent study has found.
Thinning of the peripapillary inferior-temporal retinal nerve fibre layer (RNFL) may be an early sign of neuroretinal degeneration in diabetics without diabetic retinopathy (DR), a recent study has found.
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.